Janus Henderson Group PLC Cytokinetics Inc Transaction History

Janus Henderson Group PLC

$174 Billion
Q1 2025

A detailed history of Janus Henderson Group PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,057,146 shares of CYTK stock, worth $39.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,057,146

Previous 1,024,417 3.19%

Holding current value

$39.3 Million

Previous $48.2 Million 11.83%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$40.19 - $51.12 $1.32 Million - $1.67 Million	32,729 Added 3.19%	1,057,146 $42.5 Million
Q4 2024 Feb 14, 2025	SELL	$46.36 - $58.62 $5.54 Million - $7 Million	-119,413 Reduced 10.44%	1,024,417 $48.2 Million
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $8.58 Million - $10.1 Million	167,501 Added 17.16%	1,143,830 $60.4 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $8.56 Million - $13.4 Million	178,957 Added 22.44%	976,329 $52.9 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $113 Million - $191 Million	-1,771,033 Reduced 68.95%	797,372 $55.9 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $2.02 Million - $6.27 Million	75,079 Added 3.01%	2,568,405 $214 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $11.7 Million - $14.6 Million	397,627 Added 18.97%	2,493,326 $73.5 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $17 Million - $21.3 Million	522,055 Added 33.17%	2,095,699 $68.4 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $46.7 Million - $64 Million	1,399,714 Added 804.76%	1,573,644 $55.4 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $5.69 Million - $8.12 Million	158,967 Added 1062.4%	173,930 $7.97 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $809 - $1,144	21 Added 0.14%	14,963 $725,000
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $203 - $293	-6 Reduced 0.04%	14,942 $587,000
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $118 - $184	4 Added 0.03%	14,948 $550,000
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $258,586 - $349,148	7,528 Added 101.51%	14,944 $682,000
Q3 2021 Nov 16, 2021	BUY	$18.54 - $35.74 $137,492 - $265,047	7,416 New	7,416 $265,000
Q4 2017 Feb 09, 2018	SELL	$7.25 - $15.65 $20.1 Million - $43.5 Million	-2,778,605 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.0 - $15.0 $1.12 Million - $1.41 Million	93,675 Added 3.49%	2,778,605 $0
Q2 2017 Aug 17, 2017	BUY	N/A	2,684,930	2,684,930 $32.5 Million

Others Institutions Holding CYTK

# of Institutions

400

Shares Held

128M

Call Options Held

3.66M

Put Options Held

900K

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.5B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Cytokinetics Inc Transaction History